Publikationen von F. Weber
Alle Typen
Zeitschriftenartikel (71)
61.
Zeitschriftenartikel
31 (1), S. 19 - 26 (2004)
Progressive multifocal leukencephalopathy - Diagnosis, pathogenesis, and therapeutic options. Aktuelle Neurologie 62.
Zeitschriftenartikel
10 (2), S. 165 - 169 (2004)
Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Multiple Sclerosis 63.
Zeitschriftenartikel
146 (1-2), S. 171 - 175 (2004)
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone. Journal of Neuroimmunology 64.
Zeitschriftenartikel
23 (2), S. 94 - 98 (2004)
Störungen von Affekt und Kognition bei Patienten mit Multipler Sklerose. Nervenheilkunde 65.
Zeitschriftenartikel
250 (10), S. 1224 - 1228 (2003)
Interferon-beta-1b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. Journal of Neurology 66.
Zeitschriftenartikel
36 (5), S. 247 - 247 (2003)
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone. Pharmacopsychiatry 67.
Zeitschriftenartikel
133 (1-2), S. 193 - 197 (2002)
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b. Journal of Neuroimmunology 68.
Zeitschriftenartikel
116, S. 49 - 55 (2001)
Migration of human granulocytes through reconstituted basement membrane is not dependent on matrix metalloproteinase-9 (MMP-9). Journal of Neuroimmunology 69.
Zeitschriftenartikel
116, S. 233 - 237 (2001)
Development of an ultrasensitive enzyme immunoassay for the determination of matrix metalloproteinase-9 (MMP-9) levels in normal human cerebrospinal fluid. Journal of Neuroimmunology 70.
Zeitschriftenartikel
3, S. 61 - 64 (2001)
Multiple Sklerose. Experimentelle Therapien - Hoffnung für die Zukunft? Neurotransmitter 71.
Zeitschriftenartikel
28, S. 132 - 134 (2001)
Rhabdomyolyse nach Einnahme von Venlafaxin (Trevilor®). Aktuelle Neurologie Buchkapitel (3)
72.
Buchkapitel
Koma - Metabolische Störungen - Hirntod. In: Die Intensivmedizin. 10., überarb. u. erw. Aufl., S. 635 - 643 (Hg. Burchardi, H.; Larsen, R.; Kuhlen, R.; Jauch, K.-W.; Schölmerich, J.). Springer, Heidelberg (2008)
73.
Buchkapitel
Multiple Sklerose: Pathogenese und Möglichkeiten einer individualisierten Therapie. Forschungsbericht 2007 - Max-Planck-Institut für Psychiatrie. In: Jahrbuch (Hg. Max-Planck-Gesellschaft). Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., München (2007)
74.
Buchkapitel
Postinfektiöse und postvakzinale ZNS-Erkankungen. In: Infektionserkrankungen des Zentralnervensystems. Pathogenese, Diagnose und Therapie. 2. völlig neu bearb. Aufl, S. 169 - 183 (Hg. Prange, H.; Bitsch, A.). Wissenschaftliche Verlagsgesellschaft, Stuttgart (2001)
Konferenzbeitrag (5)
75.
Konferenzbeitrag
24 (Suppl. 2), 320, S. 981 - 982 (2018)
Absence of Epstein-Barr virus seronegativity in a large cohort of patients with early multiple sclerosis. 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, GERMANY, 10. Oktober 2018 - 12. Oktober 2018. MULTIPLE SCLEROSIS JOURNAL 76.
Konferenzbeitrag
23 (3, Suppl.), P643, S. 301 - 303 (2017)
Intrathecal immunoglobulin synthesis as a predictive marker for disability progression in multiple sclerosis. 7th Joint
European Committee for Treatment and Research in Multiple Sclerosis
(ECTRIMS) Americas Committee for Treatment and Research in Multiple-Scle
rosis (ACTRIMS), Paris, FRANCE, 25. Oktober 2017 - 28. Oktober 2017. MULTIPLE SCLEROSIS JOURNAL 77.
Konferenzbeitrag
23 (3, Suppl.), P412, S. 167 - 168 (2017)
Altered grey matter networks in young patients with MS at genetic risk for Alzheimer's disease. 7th Joint
European Committee for Treatment and Research in Multiple Sclerosis
(ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, FRANCE, 25. Oktober 2017 - 28. Oktober 2017. MULTIPLE SCLEROSIS JOURNAL 78.
Konferenzbeitrag
23 (3, Suppl.), P444, S. 184 - 185 (2017)
Association of smoking but not HLA-DRB1*15:01, APOE, or body mass index with brain atrophy in early multiple sclerosis. 7th Joint
European Committee for Treatment and Research in Multiple Sclerosis
(ECTRIMS) Americas Committee for Treatment and Research in Multiple Scle
rosis (ACTRIMS), Paris, FRANCE, 25. Oktober 2017 - 28. Oktober 2017. MULTIPLE SCLEROSIS JOURNAL 79.
Konferenzbeitrag
23 (Suppl. 3), P411, S. 165 - 166 (2017)
Neuropsychological impairment in newly diagnosed early multiple sclerosis: clinical and neuropsychological characterization of a German cohort of 1124 patients. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25. Oktober 2017 - 28. Oktober 2017. MULTIPLE SCLEROSIS JOURNAL Meeting Abstract (10)
80.
Meeting Abstract
22, S. 486 - 487. 32nd Congress of the
European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
(ECTRIMS), London, ENGLAND, 14. September 2016 - 17. September 2016. (2016)
Genetic variants associated with intrathecal synthesis of IgG, IgM and IgA in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL,